Sepsis and the evolution of human increased sensitivity to lipopolysaccharide
- PMID: 33689211
- DOI: 10.1002/evan.21887
Sepsis and the evolution of human increased sensitivity to lipopolysaccharide
Abstract
Among mammals, humans are exquisitely sensitive to lipopolysaccharide (LPS), an environmentally pervasive bacterial cell membrane component. Very small doses of LPS trigger powerful immune responses in humans and can even initiate symptoms of sepsis. Close evolutionary relatives such as African and Asian monkeys require doses that are an order of magnitude higher to do the same. Why humans have evolved such an energetically expensive antimicrobial strategy is a question that biological anthropologists are positioned to help address. Here we compare LPS sensitivity in primate/mammalian models and propose that human high sensitivity to LPS is adaptive, linked to multiple immune tactics against pathogens, and part of multi-faceted anti-microbial strategy that strongly overlaps with that of other mammals. We support a notion that LPS sensitivity in humans has been driven by microorganisms that constitutively live on us, and has been informed by human behavioral changes over our species' evolution (e.g., meat eating, agricultural practices, and smoking).
Keywords: LPS sensitivity; human evolution; innate immunity; lipopolysaccharide; sepsis.
© 2021 Wiley Periodicals LLC.
References
REFERENCES
-
- Funk DJ, Parrillo JE, Kumar A. 2009. Sepsis and septic shock: a history. Crit Care Clin 25(1):83-101.viii.
-
- Fleischmann C, Scherag A, Adhikari NK, et al. 2016. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med 193(3):259-272.
-
- World Health Organization. 2011. Report on the burden of endemic health care-associated infection worldwide. Geneva, Switzerland: WHO Press. [Accessed April 24, 2019].
-
- Angus DC, Wax RS. 2001. Epidemiology of sepsis: an update. Crit Care Med 29(7 Suppl):S109-S116.
-
- Opal SM. 2010. Endotoxins and other sepsis triggers. Contrib Nephrol 167:14-24.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
